Why this Wall Street hedge fund legend sold VRX and GILD?
This billion-dollar hedge fund initiates new position in struggling pharma TEVA as exits VRX.
Is Billionaire fund guru Jim Simons switching OPK for VRX?
Ken Griffin is a man known to be raring to take a risk when it …
One of the world’s top fund managers is backing volatile healthcare stocks VRX and MNKD.
Risk-taker Dmitry Balyasny eyes advantage in the biotech world, between new initiations in TEVA, SGYP, and a major increase in OPK.
Written by Danny Cohen And Scott Matusow This past weekend at The Society for Immunotherapy …
Israel “Izzy” Englander isn’t afraid to go against the market on TEVA, VRX and ACAD.
Shares in gastrointestinal biopharma Synergy Pharmaceuticals Inc (NASDAQ:SGYP) are plunging by 30% this week, following the …
Both TRXC and MNKD offer potentially big rewards, but at what cost?